CD8A and type 1 diabetes mellitus: Indeed pro-diabetic CD8+ T cells were decreased, whereas C-peptide blood levels, a by-product of insulin production, was improved in T1D individuals who were administered a DNA plasmid encoding pro-insulin, compared to control (56).